Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lloyd

Showing results (471-480 of 486) with videos related to

Pageof 49
Sort By:
Pharmacology & Therapeutics|November 7, 2024
Lessons learned from 20 years of preclinical testing in pediatric cancersMalcolm A Smith, Peter J Houghton, Richard B Lock, et al.
Lancet (London, England)|March 10, 2024
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trialPaolo Lanzetta, Jean-François Korobelnik, Jeffrey S Heier, et al.
Ophthalmology|August 28, 2025
Intravitreal Aflibercept 8 mg in Neovascular Age-related Macular Degeneration: 96-Week Results from the Randomized Phase 3 PULSAR TrialJean-François Korobelnik, Paolo Lanzetta, Sergio Leal, et al.
Science (New York, N.Y.)|October 3, 2024
The coevolution of fungus-ant agricultureTed R Schultz, Jeffrey Sosa-Calvo, Matthew P Kweskin, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 8, 2024
Comparing Cochlear Implant Outcomes in 100 Patients With Sporadic Vestibular Schwannoma Managed With Observation, Radiosurgery, or Microsurgery: A Multi-Institutional ReviewJames R Dornhoffer, John P Marinelli, Christine M Lohse, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 6, 2019
Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencingD Gareth Evans, Claire L Hartley, Philip T Smith, et al.
Molecular Biology and Evolution|June 30, 2018
Evolution on the Biophysical Fitness Landscape of an RNA VirusAssaf Rotem, Adrian W R Serohijos, Connie B Chang, et al.
Journal of Personalized Medicine|November 26, 2025
Intravitreal Aflibercept for the Treatment of Diabetic Retinopathy Among Patients Who Completed PANORAMA: 1-Year Outcomes from the VOYAGE Extension StudyAvery W Zhou, Gail M Teagle, Liisa M Baumann, et al.
Molecular Cancer Therapeutics|April 19, 2024
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus RecommendationsFunda Meric-Bernstam, Michael W Lloyd, Soner Koc, et al.
Cancer Research|September 7, 2022
A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung CancerXing Yi Woo, Anuj Srivastava, Philip C Mack, et al.
Pageof 49

Showing results (471-480 of 486) with videos related to

Sort By:
Pageof 49
Pharmacology & Therapeutics|November 7, 2024
Lessons learned from 20 years of preclinical testing in pediatric cancersMalcolm A Smith, Peter J Houghton, Richard B Lock, et al.
Lancet (London, England)|March 10, 2024
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trialPaolo Lanzetta, Jean-François Korobelnik, Jeffrey S Heier, et al.
Ophthalmology|August 28, 2025
Intravitreal Aflibercept 8 mg in Neovascular Age-related Macular Degeneration: 96-Week Results from the Randomized Phase 3 PULSAR TrialJean-François Korobelnik, Paolo Lanzetta, Sergio Leal, et al.
Science (New York, N.Y.)|October 3, 2024
The coevolution of fungus-ant agricultureTed R Schultz, Jeffrey Sosa-Calvo, Matthew P Kweskin, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 8, 2024
Comparing Cochlear Implant Outcomes in 100 Patients With Sporadic Vestibular Schwannoma Managed With Observation, Radiosurgery, or Microsurgery: A Multi-Institutional ReviewJames R Dornhoffer, John P Marinelli, Christine M Lohse, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 6, 2019
Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencingD Gareth Evans, Claire L Hartley, Philip T Smith, et al.
Molecular Biology and Evolution|June 30, 2018
Evolution on the Biophysical Fitness Landscape of an RNA VirusAssaf Rotem, Adrian W R Serohijos, Connie B Chang, et al.
Journal of Personalized Medicine|November 26, 2025
Intravitreal Aflibercept for the Treatment of Diabetic Retinopathy Among Patients Who Completed PANORAMA: 1-Year Outcomes from the VOYAGE Extension StudyAvery W Zhou, Gail M Teagle, Liisa M Baumann, et al.
Molecular Cancer Therapeutics|April 19, 2024
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus RecommendationsFunda Meric-Bernstam, Michael W Lloyd, Soner Koc, et al.
Cancer Research|September 7, 2022
A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung CancerXing Yi Woo, Anuj Srivastava, Philip C Mack, et al.
Pageof 49